Upgrades:
Welltower (NYSE:WELL) was upgraded by equities researchers at Evercore ISI from an “in-line” rating to an “outperform” rating in a research note issued on Monday, The Fly reports. The brokerage currently has a $86.00 target price on the real estate investment trust’s stock, up from their previous target price of $77.00. Evercore ISI’s target price suggests a potential upside of 7.93% from the stock’s current price.
Several other brokerages also recently commented on WELL.
KeyCorp increased their price objective on shares of Welltower from $75.00 to
$80.00 and gave the company an “overweight” rating in a research report on
Thursday, April 15th. Royal Bank of Canada raised shares of Welltower from a
“sector perform” rating to an “outperform” rating and raised their price target
for the company from $70.00 to $82.00 in a research report on Monday, May 3rd.
Bank of America upgraded shares of Welltower from a “neutral” rating to a “buy”
rating and boosted their price objective for the stock from $73.00 to $78.00 in
a report on Tuesday, March 30th. Mizuho increased their target price on
Welltower from $60.00 to $70.00 and gave the company a “neutral” rating in a
research note on Wednesday, April 28th. Finally, Deutsche Bank
Aktiengesellschaft upped their price target on Welltower from $76.00 to $80.00
and gave the company a “buy” rating in a report on Thursday, June 3rd. Two
analysts have rated the stock with a sell rating, ten have assigned a hold
rating and ten have assigned a buy rating to the stock. The company has a
consensus rating of “Hold” and a consensus target price of $68.76. Read
more …
W. P. Carey (NYSE:WPC) was upgraded by equities researchers at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a report issued on Tuesday, The Fly reports. The brokerage currently has a $88.00 price target on the real estate investment trust's stock. JPMorgan Chase & Co.'s price target would indicate a potential upside of 13.20% from the stock's current price.
Other research analysts have also issued reports about the
stock. Evercore ISI raised shares of W. P. Carey from an "in-line"
rating to an "outperform" rating and raised their price target for
the company from $77.00 to $80.00 in a research report on Monday, May 3rd. Bank
of America reaffirmed an "underperform" rating on shares of W. P.
Carey in a research report on Tuesday, April 13th. Finally, Zacks Investment
Research raised shares of W. P. Carey from a "sell" rating to a "hold"
rating in a research report on Tuesday, April 13th. One analyst has rated the
stock with a sell rating, one has given a hold rating and three have issued a
buy rating to the company. W. P. Carey presently has a consensus rating of
"Hold" and a consensus target price of $81.00. Read
more …
Nestlé (OTCMKTS:NSRGY) was upgraded by investment analysts at Exane BNP Paribas from an "underperform" rating to a "neutral" rating in a report issued on Tuesday, The Fly reports.
Several other equities analysts also recently issued reports
on the stock. JPMorgan Chase & Co. reissued an "overweight"
rating on shares of Nestlé in a research note on Tuesday, June 1st. Morgan
Stanley reaffirmed an "overweight" rating on shares of Nestlé in a
research note on Friday, April 23rd. Barclays reaffirmed an
"overweight" rating on shares of Nestlé in a research note on Friday,
April 23rd. Societe Generale reaffirmed a "buy" rating on shares of
Nestlé in a research note on Wednesday, April 28th. Finally, Royal Bank of Canada
reissued a "sector perform" rating on shares of Nestlé in a research
note on Friday, April 23rd. Seven investment analysts have rated the stock with
a hold rating and nine have issued a buy rating to the stock. The stock
currently has an average rating of "Buy" and a consensus price target
of $127.00.
Shares of NSRGY opened at $126.72 on Tuesday. The company
has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio
of 0.60. The stock has a market capitalization of $364.96 billion, a P/E ratio
of 28.22, a price-to-earnings-growth ratio of 3.53 and a beta of 0.37. The
firm's 50 day moving average price is $120.91. Nestlé has a 1 year low of
$104.50 and a 1 year high of $127.45. Read
more …
AT&T (NYSE:T) was upgraded by equities research analysts at Scotiabank from a “sector underperform” rating to a “sector perform” rating in a note issued to investors on Wednesday, Briefing.com reports. The brokerage presently has a $31.00 price objective on the technology company’s stock, up from their previous price objective of $28.00. Scotiabank’s target price would suggest a potential upside of 6.53% from the company’s current price.
A number of other brokerages have also recently issued
reports on T. Morgan Stanley cut their price objective on shares of AT&T
from $34.00 to $32.00 and set an “equal weight” rating for the company in a
research note on Monday, May 24th. Deutsche Bank Aktiengesellschaft upped their
price objective on shares of AT&T from $31.00 to $34.00 in a research note
on Wednesday, April 28th. UBS Group raised shares of AT&T from a “neutral”
rating to a “buy” rating and upped their price objective for the company from
$32.00 to $35.00 in a research note on Friday, May 21st. New Street Research
upgraded shares of AT&T from a “neutral” rating to a “buy” rating and set a
$35.00 price target for the company in a report on Friday, May 21st. Finally,
Oppenheimer reiterated a “hold” rating on shares of AT&T in a report on
Monday, April 26th. Two analysts have rated the stock with a sell rating, six
have issued a hold rating and eight have assigned a buy rating to the stock.
AT&T has an average rating of “Hold” and an average price target of $31.81.
Read
more …
Enbridge (NYSE:ENB) (TSE:ENB) was upgraded by Credit Suisse Group from a “neutral” rating to an “outperform” rating in a research note issued on Thursday, The Fly reports.
Other research analysts also recently issued reports about
the company. Zacks Investment Research downgraded Enbridge from a “buy” rating
to a “hold” rating and set a $42.00 price target on the stock. in a research
note on Monday. Argus upped their price target on Enbridge from $40.00 to
$43.00 and gave the stock a “buy” rating in a research note on Tuesday, May
25th. Tudor Pickering reissued a “buy” rating and issued a C$52.00 price
objective on shares of Enbridge in a research note on Friday, June 11th.
Finally, Wells Fargo & Company increased their price objective on Enbridge
from $50.00 to $51.00 and gave the stock an “overweight” rating in a research
note on Monday, May 17th. One equities research analyst has rated the stock
with a hold rating and twelve have assigned a buy rating to the company’s
stock. The stock currently has an average rating of “Buy” and an average price
target of $51.00. Read
more …
Downgrades:
Kinder Morgan (NYSE:KMI) was downgraded by analysts at The Goldman Sachs Group from a “neutral” rating to a “sell” rating in a note issued to investors on Sunday, The Fly reports.
Several other analysts have also weighed in on KMI. Morgan
Stanley lowered shares of Kinder Morgan from an “equal weight” rating to an
“underweight” rating and set a $18.00 target price for the company. in a
research note on Wednesday, May 26th. Citigroup boosted their target price on
shares of Kinder Morgan from $15.50 to $17.00 in a research note on Tuesday,
April 27th. TD Securities boosted their target price on shares of Kinder Morgan
from $19.00 to $20.00 and gave the company a “buy” rating in a research note on
Thursday, June 3rd. Wells Fargo & Company reiterated an “underweight”
rating on shares of Kinder Morgan in a research note on Wednesday, May 19th.
Finally, TheStreet upgraded shares of Kinder Morgan from a “c+” rating to a “b”
rating in a research report on Wednesday, April 21st. Five analysts have rated
the stock with a sell rating, nine have issued a hold rating and five have
assigned a buy rating to the stock. The company currently has an average rating
of “Hold” and an average target price of $16.53. Read
more …
Diageo (NYSE:DEO) was downgraded by investment analysts at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating in a research report issued on Monday, The Fly reports.
Several other equities research analysts have also issued
reports on the stock. Berenberg Bank reaffirmed a “hold” rating on shares of
Diageo in a report on Friday, May 14th. Argus raised shares of Diageo from a
“hold” rating to a “buy” rating and set a $225.00 target price on the stock in
a report on Friday, June 4th. Zacks Investment Research lowered shares of
Diageo from a “buy” rating to a “hold” rating and set a $176.00 target price on
the stock. in a report on Tuesday, March 30th. Morgan Stanley reissued an
“overweight” rating on shares of Diageo in a report on Thursday, May 13th.
Finally, Citigroup reissued a “neutral” rating on shares of Diageo in a report
on Thursday, May 13th. One research analyst has rated the stock with a sell
rating, five have assigned a hold rating and eleven have given a buy rating to
the stock. The company has an average rating of “Buy” and an average price
target of $188.33. Read
more …
Fastenal (NASDAQ:FAST) was downgraded by equities research analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating in a report released on Tuesday, The Fly reports. They currently have a $48.00 target price on the stock, down from their previous target price of $53.00. Morgan Stanley's price objective points to a potential downside of 8.97% from the stock's current price.
A number of other brokerages have also recently weighed in
on FAST. Robert W. Baird increased their price target on shares of Fastenal
from $50.00 to $53.00 and gave the stock an "outperform" rating in a
research note on Wednesday, April 14th. Zacks Investment Research cut shares of
Fastenal from a "hold" rating to a "sell" rating and set a
$54.00 price target for the company. in a research note on Monday, April 5th.
Three research analysts have rated the stock with a sell rating, five have
given a hold rating and three have given a buy rating to the company's stock.
Fastenal has a consensus rating of "Hold" and a consensus target
price of $48.00. Read
more …
Nutrien (NYSE:NTR) was downgraded by research analysts at Raymond James from a “strong-buy” rating to an “outperform” rating in a research report issued to clients and investors on Tuesday, PriceTargets.com reports. They presently have a $82.00 price objective on the stock, up from their prior price objective of $75.00. Raymond James’ price objective suggests a potential upside of 30.55% from the company’s current price.
A number of other research firms have also recently
commented on NTR. Morgan Stanley increased their target price on shares of
Nutrien from $56.00 to $62.00 and gave the company an “equal weight” rating in
a research report on Monday, May 10th. Royal Bank of Canada raised their price
target on shares of Nutrien from $60.00 to $62.00 and gave the stock an
“outperform” rating in a report on Wednesday, April 14th. Zacks Investment
Research raised shares of Nutrien from a “hold” rating to a “buy” rating and
set a $68.00 price target for the company in a report on Friday, May 28th.
JPMorgan Chase & Co. raised their price target on shares of Nutrien from
$63.00 to $65.00 and gave the stock an “overweight” rating in a report on
Wednesday, May 5th. Finally, TD Securities raised their price target on shares
of Nutrien from $66.00 to $69.00 and gave the stock a “buy” rating in a report
on Friday, April 30th. One investment analyst has rated the stock with a sell
rating, three have assigned a hold rating and eight have given a buy rating to
the company. The stock has an average rating of “Buy” and a consensus target
price of $63.10. Read
more …
Omega Healthcare Investors (NYSE:OHI) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating in a note issued to investors on Thursday, Price Targets.com reports. They presently have a $39.00 target price on the real estate investment trust's stock, down from their previous target price of $41.00. Scotiabank's price target would suggest a potential upside of 4.73% from the company's current price. The analysts noted that the move was a valuation call.
A number of other brokerages have also recently commented on
OHI. TheStreet upgraded shares of Omega Healthcare Investors from a
"c+" rating to a "b-" rating in a research report on
Monday, April 5th. Wolfe Research assumed coverage on shares of Omega
Healthcare Investors in a research report on Monday. They issued a "peer
perform" rating and a $43.00 target price for the company. JMP Securities
reiterated an "outperform" rating and issued a $43.00 target price on
shares of Omega Healthcare Investors in a research report on Monday, May 10th.
Finally, Zacks Investment Research upgraded shares of Omega Healthcare
Investors from a "sell" rating to a "hold" rating in a
research report on Thursday, April 29th. Five investment analysts have rated
the stock with a hold rating and six have given a buy rating to the company.
The stock presently has an average rating of "Buy" and an average
target price of $37.79. Read
more …
Devon Energy (NYSE:DVN) was downgraded by research analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating in a note issued to investors on Friday, The Fly reports. They currently have a $32.00 price target on the energy company's stock, up from their prior price target of $28.00. Morgan Stanley's target price suggests a potential upside of 15.98% from the company's current price.
Several other research firms also recently commented on DVN.
Mizuho lifted their price objective on Devon Energy from $29.00 to $35.00 and
gave the stock a "buy" rating in a report on Monday, May 17th.
Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised
their target price on Devon Energy from $24.00 to $29.00 in a research note on
Tuesday, March 23rd. TheStreet raised Devon Energy from a "d+" rating
to a "c" rating in a research note on Tuesday, May 4th. Truist raised
their target price on Devon Energy from $30.00 to $35.00 in a research note on
Monday, March 8th. Finally, Zacks Investment Research cut Devon Energy from a
"buy" rating to a "hold" rating and set a $29.00 target
price on the stock. in a research note on Tuesday, May 18th. Four investment
analysts have rated the stock with a hold rating, seventeen have issued a buy
rating and two have issued a strong buy rating to the stock. The stock
currently has an average rating of "Buy" and a consensus price target
of $26.68. Read
more …
Comments
Post a Comment